These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21840057)

  • 41. Screening of colorectal cancer.
    Winawer SJ
    Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemoprevention in colorectal neoplasias: what is practical and feasible?
    Ricciardiello L; Roda E; Bazzoli F
    Dig Dis; 2002; 20(1):70-2. PubMed ID: 12145422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant.
    Wong G; Li MW; Howard K; Hua DK; Chapman JR; Bourke M; Turner R; Tong A; Craig JC
    Nephrol Dial Transplant; 2013 Apr; 28(4):917-26. PubMed ID: 23182812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aspirin as a chemoprevention agent for colorectal cancer.
    Lee CS; McNamara D; O'Morain CA
    Curr Drug Metab; 2012 Nov; 13(9):1313-22. PubMed ID: 22493984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemoprevention of arylamine-induced colorectal aberrant crypts.
    Feng Y; Neale JR; Doll MA; Hein DW
    Exp Biol Med (Maywood); 2008 Jan; 233(1):71-5. PubMed ID: 18156308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Costs and consequences of clopidogrel versus aspirin for secondary prevention of ischaemic events in (high-risk) atherosclerotic patients in Sweden: a lifetime model based on the CAPRIE trial and high-risk CAPRIE subpopulations.
    Logman JF; Heeg BM; Herlitz J; van Hout BA
    Appl Health Econ Health Policy; 2010; 8(4):251-65. PubMed ID: 20578780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Of timing and surrogates: a way forward for cancer chemoprevention.
    Thompson PA; Gerner EW
    Clin Cancer Res; 2011 Jun; 17(11):3509-11. PubMed ID: 21498391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemoprevention of colorectal cancer.
    Das D; Arber N; Jankowski JA
    Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness in the prevention of colorectal cancer.
    Sonnenberg A
    Gastroenterol Clin North Am; 2002 Dec; 31(4):1069-91. PubMed ID: 12489279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients.
    Lip GY; Lanitis T; Mardekian J; Kongnakorn T; Phatak H; Dorian P
    Stroke; 2015 Oct; 46(10):2830-7. PubMed ID: 26316345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. C-reactive protein and risk of colorectal adenoma according to celecoxib treatment.
    Chan AT; Sima CS; Zauber AG; Ridker PM; Hawk ET; Bertagnolli MM
    Cancer Prev Res (Phila); 2011 Aug; 4(8):1172-80. PubMed ID: 21816845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial.
    Bertagnolli MM; Hsu M; Hawk ET; Eagle CJ; Zauber AG;
    Cancer Prev Res (Phila); 2010 May; 3(5):588-96. PubMed ID: 20403998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemoprevention, risk reduction, therapeutic prevention, or preventive therapy?
    Meyskens FL; McLaren CE
    J Natl Cancer Inst; 2010 Dec; 102(24):1815-7. PubMed ID: 21115881
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials.
    Veettil SK; Teerawattanapong N; Ching SM; Lim KG; Saokaew S; Phisalprapa P; Chaiyakunapruk N
    Onco Targets Ther; 2017; 10():2689-2700. PubMed ID: 28579807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Familiar drugs may prevent cancer.
    Sharma RA; Gescher AJ; O'Byrne KJ; Steward WP
    Postgrad Med J; 2001 Aug; 77(910):492-7. PubMed ID: 11470927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of a high-selenium yeast supplement on celecoxib plasma levels: a randomized phase II trial.
    Frank DH; Roe DJ; Chow HH; Guillen JM; Choquette K; Gracie D; Francis J; Fish A; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):299-303. PubMed ID: 14973093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Faecal occult blood screening for colorectal cancer: is it cost-effective?
    Whynes DK; Neilson AR; Walker AR; Hardcastle JD
    Health Econ; 1998 Feb; 7(1):21-9. PubMed ID: 9541081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aspirin and Delayed Chemoprevention of Colorectal Cancer.
    Giovannucci E
    Clin Chem; 2018 Nov; 64(11):1668-1669. PubMed ID: 30068694
    [No Abstract]   [Full Text] [Related]  

  • 59. Topical inhibition of oral carcinoma cell with polymer delivered celecoxib.
    Wang Z; Polavaram R; Shapshay SM
    Cancer Lett; 2003 Jul; 198(1):53-8. PubMed ID: 12893430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Aspirin and cancer: evidence of a prophylactic effect].
    Algra AM; Nortier JW
    Ned Tijdschr Geneeskd; 2013; 157(17):A5189. PubMed ID: 23614860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.